Please assess the completion status of the following clinical trial:

Trial Title: Pharmacokinetics of Asacol 2.4 g/Day and Lialda 2.4 g/Day in Healthy Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Males or females between 18 and 45 years of age, inclusive, at screening and in good general health based on medical history, physical examination, and laboratory evaluation;~* If female, must be (as documented by patient reported medical history):~* postmenopausal (at least 1 year without spontaneous menses), or~* surgically sterile (tubal ligation or hysterectomy), or~* using acceptable contraception \[e.g., sexual partner with non-reversed vasectomy (with azoospermia in 2 tests), 2 barrier methods (e.g., condom, diaphragm, or spermicide), or intra-uterine device\];~* Body mass index (BMI) between 18 and 32 kg/m2, inclusive;~* Able to swallow the assigned study medication tablet whole; and,~* Able to fulfill the requirements of the protocol and provide written informed consent.~Exclusion Criteria:~* History or presence of any condition or gastrointestinal (GI) surgery causing malabsorption or an effect on GI motility;~* Any uncontrolled acute disease or major surgical operation requiring hospitalization within 1 month of screening;~* History of diabetes, syncope, cardiovascular, hepatic, or renal disease;~* Uncontrolled chronic diseases such as hypertension, systemic lupus erythematosus, or rheumatoid arthritis;~* History of cancer within the last 5 years (except for basal cell carcinoma with a documented 6-month remission);~* Any known enzyme-inducer, enzyme-inhibitor, or reported chronic exposure to enzyme-inducers such as paint solvents or pesticides within 30 days of treatment;~* Any prescription drug or herbal remedy within 14 days prior to scheduled dosing

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): Asacol 6x400 mg Q24h at 7 am for 7 days
- 2 (Type: EXPERIMENTAL): Asacol 2x400 mg Q8h at 7 am, 3 pm, and 11 pm for 7 days
- 3 (Type: EXPERIMENTAL): Lialda 2x1.2g Q24h at 7 am for 7 days

Based on this trial design, predict the completion outcome and termination type (if applicable).